Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 9;19(1):25.
doi: 10.1186/s12954-022-00601-z.

The impact of the COVID-19 pandemic on illicit drug supply, drug-related behaviour of people who use drugs and provision of drug related services in Georgia: results of a mixed methods prospective cohort study

Affiliations

The impact of the COVID-19 pandemic on illicit drug supply, drug-related behaviour of people who use drugs and provision of drug related services in Georgia: results of a mixed methods prospective cohort study

David Otiashvili et al. Harm Reduct J. .

Abstract

Background: This study examines the effects of COVID-19 related restrictions on the supply of illicit drugs, drug-use behaviour among people who use drugs (PWUD) regularly (at least weekly), and drug-related service provision in Tbilisi, Georgia.

Methodology: In this mixed methods study, a cohort of 50 Georgian PWUD recruited through a snow-ball sampling participated in a bi-weekly online survey in April-September, 2020. They also took part in the qualitative telephone interviews at 12- and 24-week follow-up time points. In addition, four key informants (field experts) were interviewed monthly to assess their perceptions of changes in the illicit drug market and drug service delivery.

Results: Mean age in the sample was 36 (range 18-60); 39 (78%) were males. Perceived availability of drugs was reduced during the lockdown, and many PWUD switched to alternative substances when preferred drugs were not available. On average, participants used significantly fewer substances over the course of the study, from 3.5 substances in the preceding 14 days to 2.1 (aOR 0.92; 95% CI 0.90-0.94). Consumption of cannabis products declined significantly (aOR 0.89; 95% CI 0.84-0.95), likewise alcohol (aOR 0.94; 95% CI 0.88-1.0), diverted medicinal methadone (aOR 0.85; 95% CI 0.8-0.9) and diverted medicinal buprenorphine (aOR 0.91; 95% CI 0.84-0.99). PWUD cited fewer contacts with drug dealers, the lack of transportation, and the lack of conventional recreational environment as the main reasons for these changes. When access to sterile injection equipment was limited, PWUD exercised risk-containing injection behaviours, such as buying drugs in pre-filled syringes (aOR 0.88; 95% CI 0.80-0.96). Harm reduction and treatment programs managed to adopt flexible strategies to recover services that were affected during the initial stage of the pandemic.

Conclusions: COVID-19-related restrictive measures mediated specific changes in supply models and drug-use behaviours. While adjusting to the new environment, many PWUD would engage in activities that put them under increased risk of overdose and blood-borne infections. Harm reduction and treatment services need to develop and implement protocols for ensuring uninterrupted service delivery during lockdowns, in anticipation of the similar epidemics or other emergency situations.

Keywords: COVID-19; Drug-use behaviour; Georgia; Illicit drug supply.

PubMed Disclaimer

Conflict of interest statement

The authors declared that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Proportion of respondents (%) reporting at baseline the use of particular drugs in the past 12 months (N = 50). Note: the sum exceeds 100% due to the use of multiple substances by individual participants; Vint refers to a home-made long-acting stimulant prepared through the reduction of pseudoephedrine
Fig. 2
Fig. 2
Number of respondents reporting the use of particular drugs in the past 14 days (10 most prevalent drugs) (N = 50), April–September, 2020. Note: the sum exceeds N = 50 due to the use of multiple substances by individual participants; *-reduction in the use was statistically significant; exact results of the tests are shown in Table 2
Fig. 3
Fig. 3
Number of respondents reporting a specific injection risk behaviour in the past 14 days (N = 50), April–September, 2020

Similar articles

Cited by

References

    1. European Monitoring Centre for Drugs and Drug Addiction . Impact of COVID-19 on drug markets, drug use, drug-related harms and responses in east European Neighbourhood Policy countries. EMCDDA: Publications Office of the European Union, Luxembourg; 2020.
    1. European Monitoring Centre for Drugs and Drug Addiction. Impact of COVID-19 on patterns of drug use and drugrelated harms in Europe. Lisbon: EMCDDA; 2020.
    1. Morin KA, Acharya S, Eibl JK, Marsh DC. Evidence of increased Fentanyl use during the COVID-19 pandemic among opioid agonist treatment patients in Ontario, Canada. Int J Drug Policy. 2020;90:103088. - PMC - PubMed
    1. Dietze PM, Peacock A. Illicit drug use and harms in Australia in the context of COVID-19 and associated restrictions: anticipated consequences and initial responses. Drug Alcohol Rev. 2020;39(4):297–300. - PMC - PubMed
    1. Vasylyeva TI, Smyrnov P, Strathdee S, Friedman SR. Challenges posed by COVID-19 to people who inject drugs and lessons from other outbreaks. J Int AIDS Soc. 2020;23(7):e25583. - PMC - PubMed

Publication types